The 1987 Additions include administrative materials, 1960-1980; board of trustees materials, 1940-1984; Committee of Revision correspondence; and correspondence and reports of the Drug Standards Laboratory and the National Formulary. Where possible, the records have been arranged to parallel the records in earlier accessions.

Administrative Materials encompass scattered convention materials (1960 and 1975), executive correspondence and “letters,” and special meeting materials of 1973. The 1973 special meeting documentation is complete, with background material, correspondence and transcriptions. This meeting was a watershed in USPC history and these records aid in revealing not only the internal processes of the organization, but also the concerns of members and delegates on the future of the USPC. Sound recordings of the 1975 Open Conference are also available in the Sound and Visual Archives; they provide an historical as well as a scientific backdrop for understanding the revision processes of the USPC. Speakers from industry, the Food and Drug Administration, and academia delivered addresses relating to revision committee topics such as bioavailability. Unfortunately, the speakers on these tapes are not always identified.

The Board of Trustees (1940-1984) materials again are incomplete and include financial committee letters, memoranda, and minutes of board meetings.

The largest series within the 1987 additions consists of records of the Committee of Revision . This series includes correspondence and conventions of allied professional associations (1952-1968); correspondence, reports, and memoranda of the Subcommittee on Scope and its various panels and scattered admission lists for the United States Pharmacopeia (USP); and subject correspondence (1942-1961) mainly dealing with drugs that is arranged alphabetically by pharmaceutical or chemical name.

The fourth series is the Drug Standards Laboratory , 1960-1974, which was incorporated into the USPC in 1975. The DSL records are subarranged into three series: administration, projects, and subject files. Administrative records include background and historical materials, budgets, and meeting correspondence and memoranda. The project files include grant proposals and project status reports. Unfortunately, few reports in the collection specifically document the research on pharmaceuticals tested by the laboratory, and in general, the projects are not well documented. However, the monthly and quarterly reports are fairly complete, and they shed some light on the kinds of projects undertaken by DSL if not the step-by-step history of each project. Provisional monographs (1963-67) summarize findings on drugs that were tested by DSL. Lastly, subject files include miscellaneous topics arranged alphabetically. These are particularly strong on correspondence with the World Health Organization (WHO), 1969-1974.

The last series in the 1987 additions to the USPC is National Formulary materials, 1961-1974. This series is comprised of admission panels, alphabetical correspondence, and subject files. The admission panels (1965-1974) appear fairly complete, with a strong concentration on correspondence, memoranda and reports of drugs and pharmaceuticals being considered for admission in the National Formulary. Alphabetical correspondence (1968-1974) is arranged by individual or company name and is very miscellaneous in subject matter. The subject files (1956-1974) contain scattered correspondence and memoranda on various drug topics such as expiration dates and microbiological contamination.